Open Access

SGLT2 inhibitors in practice (part 4): initiating heart failure treatment in hospital

Event: ESC Congress 2022
Topic: Chronic Heart Failure, Other
Session type: Satellite Symposium
Sponsored by Boehringer Ingelheim & Eli Lilly
Date: 28 August 2022
Time: 15:30 - 16:15

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Introduction and recap.

Speaker: Professor J. Butler (Jackson, US)
Thumbnail

What is the evidence for SGLT2 inhibitors in HF?

Speaker: Professor P. Ponikowski (Wroclaw, PL)
Thumbnail

Implementing in-hospital initiation of an SGLT2 inhibitor in my practice.

Speaker: Doctor M. Costanzo (Naperville, US)
Thumbnail

Panel discussion.

Speaker: Professor S. Anker (Berlin, DE)
Thumbnail

SGLT2 inhibitors in practice: what are the next steps?

Speaker: Professor S. Anker (Berlin, DE)
Thumbnail

5 speakers from this session

Professor Javed Butler

The University of Mississippi Medical Center, Jackson (United States of America)
71 presentations
5 followers

Professor Piotr Ponikowski

Wroclaw Medical University, Wroclaw (Poland)
68 presentations
9 followers

Doctor Maria Rosa Costanzo

Advocate Heart Institute, Naperville (United States of America)
23 presentations
1 follower

Professor Stefan Anker

Charite Universitatsmedizin Berlin, Berlin (Germany)
116 presentations
4 followers

Professor Stefan Anker

Charite Universitatsmedizin Berlin, Berlin (Germany)
116 presentations
4 followers

This platform is supported by

logo Novo Nordisk